SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 9, 2001
United Therapeutics Corporation
| Delaware | 0-26301 | 52-1984749 | ||
|
|
||||
| (State or Other | (Commission | (I.R.S. Employer | ||
| Jurisdiction of | File Number) | Identification Number) | ||
| Incorporation) |
| 1110 Spring Street | |||||
| Silver Spring, MD | 20910 | ||||
|
|
|||||
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code:
(301) 608-9292
Item 5. Other Events.
On August 9, 2001, the Registrant issued a press release attached hereto as Exhibit 99 and incorporated herein.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
| Exhibit No. | Description of Exhibit | ||
| 99 | Press release of August 9, 2001 | ||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| United Therapeutics Corporation | ||||||
| (Registrant) | ||||||
| Date: August 15, 2001 | By: /s/ Fred T. Hadeed | |||||
| Name: Fred T. Hadeed | ||||||
| Title: Chief Financial Officer | ||||||
212406
Exhibit Index
| Exhibit No. | Description of Exhibit | ||
| 99 | Press release of August 9, 2001 | ||